drugset / Trial / NCT02480998
Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study evaluates the safety, tolerability and immunogenicity of IL-YANG quadrivalent vaccine versus IL-YANG trivalent vaccine after a single intramuscular administration in healthy Korean males and females 19 to \< 65 years of age.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IL-YANG Flu Vaccine QIV | Vaccine | 0.5 ml | Intramuscular |
| Comparator | IL-YANG Flu Vaccine TIV | Vaccine | 0.5 ml | Intramuscular |